About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
International Journal of Clinical Pharmacology and Therapeutics
›
top-articles
International Journal of Clinical Pharmacology and Therapeutics
0.7
(top 50%)
impact factor
3.2K
(top 10%)
papers
36.2K
(top 10%)
citations
66
(top 10%)
h
-index
0.7
(top 50%)
impact factor
3.4K
all documents
37.6K
doc citations
105
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
International Journal of Clinical Pharmacology and Therapeutics
2008
1,203
2
A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology
International Journal of Clinical Pharmacology and Therapeutics
2002
428
3
P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
International Journal of Clinical Pharmacology and Therapeutics
2000
333
4
Basic characteristics and representativeness of the German Disease Analyzer database
International Journal of Clinical Pharmacology and Therapeutics
2018
261
5
Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies
International Journal of Clinical Pharmacology and Therapeutics
2009
237
6
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
International Journal of Clinical Pharmacology and Therapeutics
2010
213
7
Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use
International Journal of Clinical Pharmacology and Therapeutics
2000
206
8
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling
International Journal of Clinical Pharmacology and Therapeutics
1997
183
9
The effect of food on the absorption and pharmacokinetics of rivaroxaban
International Journal of Clinical Pharmacology and Therapeutics
2013
166
10
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure
International Journal of Clinical Pharmacology and Therapeutics
2002
160
11
Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 2002
International Journal of Clinical Pharmacology and Therapeutics
2007
152
12
Drug interactions with St. Johns Wort (Hypericum perforatum): a review of the clinical evidence
International Journal of Clinical Pharmacology and Therapeutics
2004
150
13
Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban an oral, direct Factor Xa inhibitor in healthy subjects
International Journal of Clinical Pharmacology and Therapeutics
2007
150
14
Nitazoxanide: pharmacokinetics and metabolism in man
International Journal of Clinical Pharmacology and Therapeutics
2000
145
15
Gender differences in pharmacokinetics and pharmacodynamics
International Journal of Clinical Pharmacology and Therapeutics
1999
139
16
Benfotiamine in the treatment of diabetic polyneuropathy a three-week randomized, controlled pilot study (BEDIP Study)
International Journal of Clinical Pharmacology and Therapeutics
2005
136
17
What do primary care patients think about generic drugs?
International Journal of Clinical Pharmacology and Therapeutics
2005
134
18
P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
International Journal of Clinical Pharmacology and Therapeutics
2000
130
19
Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison
International Journal of Clinical Pharmacology and Therapeutics
2000
129
20
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY Study
International Journal of Clinical Pharmacology and Therapeutics
2004
129
21
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
International Journal of Clinical Pharmacology and Therapeutics
2012
126
22
Hubble-bubble (water pipe) smoking: levels of nicotine and cotinine in plasma, saliva and urine
International Journal of Clinical Pharmacology and Therapeutics
2002
116
23
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences
International Journal of Clinical Pharmacology and Therapeutics
2004
114
24
Hazardous pharmacokinetic interaction of Saint John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporin
International Journal of Clinical Pharmacology and Therapeutics
2000
113
25
Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials
International Journal of Clinical Pharmacology and Therapeutics
2003
112
26
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb
International Journal of Clinical Pharmacology and Therapeutics
1998
112
27
Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans
International Journal of Clinical Pharmacology and Therapeutics
2015
111
28
Statins differ in their ability to block NF-kB activation in human blood monocytes
International Journal of Clinical Pharmacology and Therapeutics
2003
111
29
Pharmacological insights from P-glycoprotein knockout mice
International Journal of Clinical Pharmacology and Therapeutics
1998
110
30
The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia
International Journal of Clinical Pharmacology and Therapeutics
2000
103
31
Predictability of the effects of race or ethnicity on pharmacokinetics of drugs
International Journal of Clinical Pharmacology and Therapeutics
2000
101
32
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem
International Journal of Clinical Pharmacology and Therapeutics
2006
100
33
A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans
International Journal of Clinical Pharmacology and Therapeutics
2001
98
34
Infliximab in chronic ocular inflammation
International Journal of Clinical Pharmacology and Therapeutics
2005
97
35
DNA repair in resistance to alkylating anticancer drugs
International Journal of Clinical Pharmacology and Therapeutics
2002
96
36
The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients
International Journal of Clinical Pharmacology and Therapeutics
1996
95
37
Pharmacokinetics and bioavailability of the flavonol quercetin in humans
International Journal of Clinical Pharmacology and Therapeutics
1999
93
38
Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis
International Journal of Clinical Pharmacology and Therapeutics
2002
92
39
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors
International Journal of Clinical Pharmacology and Therapeutics
2002
92
40
Effects of obesity on the cytochrome P450 enzyme system
International Journal of Clinical Pharmacology and Therapeutics
1999
92
41
Effect of food on the pharmacokinetic profile of trans-resveratrol
International Journal of Clinical Pharmacology and Therapeutics
2008
91
42
First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes
International Journal of Clinical Pharmacology and Therapeutics
2003
90
43
Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters
International Journal of Clinical Pharmacology and Therapeutics
2005
89
44
P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound
International Journal of Clinical Pharmacology and Therapeutics
1998
87
45
An extract of Petasites hybridus is effective in the prophylaxis of migraine
International Journal of Clinical Pharmacology and Therapeutics
2000
85
46
The MDR1 3435 polymorphism in patients with rheumatoid arthritis
International Journal of Clinical Pharmacology and Therapeutics
2004
85
47
Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects
International Journal of Clinical Pharmacology and Therapeutics
2004
83
48
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers
International Journal of Clinical Pharmacology and Therapeutics
1998
83
49
Population pharmacokinetic meta-analysis with efavirenz
International Journal of Clinical Pharmacology and Therapeutics
2002
82
50
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen
International Journal of Clinical Pharmacology and Therapeutics
2005
82
site/software ©
exaly
; All materials licenced under
CC by-SA
.